JapanStake
Pharmaceutical · Fiscal year end Mar 31

SEIKAGAKU CORPORATION

4548

生化学工業株式会社

FIGI BBG000BK93S64548.T4548 JPCorp. no. 9010001048285

Latest half-year results

First half · fiscal year to 2026-03 · filed 2025-11-12

For the first half of the fiscal year to 2026-03: Revenue ¥17.9 billion (-11.4% YoY), Ordinary income ¥0.5 billion (-77.4% YoY), Net income ¥0.2 billion (-88.1% YoY).

This periodYear on year
Revenue¥17.9bn-11.4%
Ordinary profit¥531m-77.4%
Net profit to owners¥229m-88.1%

From the securities report on EDINET, which states no forecast. History via /v1/companies/4548/earnings-releases.

Financials

Japan GAAP · consolidated · fiscal year to 2026-03-31
Revenue
¥36.6bn
Net income
¥1.5bn
ROE
2.0%
Equity ratio
87.2%
Dividend / share
¥30
Employees
1,142
Revenue · ¥bn
FY2022: ¥34.9bn 34.9 FY2022FY2023: ¥33.5bn 33.5 FY2023FY2024: ¥36.2bn 36.2 FY2024FY2025: ¥39.4bn 39.4 FY2025FY2026: ¥36.6bn 36.6 FY2026
Net income · ¥bn
FY2022: ¥3.7bn 3.73 FY2022FY2023: ¥2.2bn 2.24 FY2023FY2024: ¥2.2bn 2.19 FY2024FY2025: ¥1.2bn 1.21 FY2025FY2026: ¥1.5bn 1.47 FY2026
Fiscal yearRevenueNet incomeTotal assetsNet assetsROEEPSOperating CF
2026-03-31¥36.6bn¥1.5bn¥86.3bn¥75.3bn2.0%¥26.99−¥1.3bn
2025-03-31¥39.4bn¥1.2bn¥83.9bn¥73.2bn1.7%¥22.25¥4.4bn
2024-03-31¥36.2bn¥2.2bn¥81.8bn¥72.3bn3.1%¥40.08¥0.5bn
2023-03-31¥33.5bn¥2.2bn¥75.6bn¥67.2bn3.3%¥40.49¥1.6bn
2022-03-31¥34.9bn¥3.7bn¥75.2bn¥66.3bn5.7%¥66.32¥8.2bn

Indicators

Computed by us from filings · fiscal year to 2026-03-31
MetricValuePercentile among listed companies
ROE, %211
Ordinary margin0.045834.8
Equity ratio, %87.296.7
Revenue growth-0.06939.3
Net income growth0.213357.5
Operating cash flow / assets-0.015612.7
Policy-uncertainty measure0.54 Share of the report's text discussing policy-related uncertainty, by policy area. Proprietary text method.
Regulation 1
Ownership activity 0 filer(s) stated they may make proposals in 365 days; 0 new 5% holder(s) in 180 days; net stake change 0.00pt in 90 days; 4.3% held by other listed companies.

Results wording balance: 0.00. Proprietary text method; it describes the wording only and does not interpret context.

Interest example: if all ¥300m of reported debt repriced by 50 basis points, a year's interest would rise by ¥2m. Our arithmetic only, not a forecast: fixed-rate debt and hedges are ignored.

Via /v1/companies/4548/indicators. Descriptive figures, not a rating and not investment advice.

From other filings

As the company states them
Internal control, 2026-06-18: see filing 上記の評価の結果、2026年3月31日現在の当社及び連結子会社の財務報告に係る内部統制は有効であると判断しました。 Filing

Segments, votes and tender offers

Stated in EDINET filings
Segments: Pharmaceutical, LAL. /v1/companies/4548/segments
Latest voting result: 2026-06-19 · 剰余金の処分の件 · passed. /v1/companies/4548/voting

Ownership changes

All companies →

Trades by 5% holders

From the 60-day trade tables in 5% reports
¥615¥650¥685 2025-07-112025-10-16 2025-10-16 · bought 13,000 @ ¥663 · 株式会社開生社2025-10-15 · bought 13,000 @ ¥657 · 株式会社開生社2025-10-14 · bought 13,000 @ ¥648 · 株式会社開生社2025-10-10 · bought 13,000 @ ¥658 · 株式会社開生社2025-10-09 · bought 13,000 @ ¥659 · 株式会社開生社2025-10-08 · bought 13,000 @ ¥667 · 株式会社開生社2025-10-07 · bought 13,000 @ ¥667 · 株式会社開生社2025-10-06 · bought 13,000 @ ¥668 · 株式会社開生社2025-10-03 · bought 13,000 @ ¥662 · 株式会社開生社2025-10-02 · bought 13,000 @ ¥657 · 株式会社開生社2025-10-01 · bought 13,000 @ ¥658 · 株式会社開生社2025-09-30 · bought 13,000 @ ¥666 · 株式会社開生社2025-09-29 · bought 13,000 @ ¥674 · 株式会社開生社2025-09-26 · bought 13,000 @ ¥683 · 株式会社開生社2025-09-25 · bought 13,000 @ ¥679 · 株式会社開生社2025-09-24 · bought 13,000 @ ¥680 · 株式会社開生社2025-09-22 · bought 13,000 @ ¥685 · 株式会社開生社2025-09-19 · bought 13,000 @ ¥682 · 株式会社開生社2025-09-18 · bought 13,000 @ ¥676 · 株式会社開生社2025-09-17 · bought 13,000 @ ¥675 · 株式会社開生社2025-09-16 · bought 13,000 @ ¥674 · 株式会社開生社2025-09-12 · bought 13,000 @ ¥672 · 株式会社開生社2025-09-11 · bought 13,000 @ ¥674 · 株式会社開生社2025-09-10 · bought 13,000 @ ¥680 · 株式会社開生社2025-09-09 · bought 13,000 @ ¥684 · 株式会社開生社2025-09-08 · bought 13,000 @ ¥679 · 株式会社開生社2025-09-05 · bought 13,000 @ ¥677 · 株式会社開生社2025-09-04 · bought 13,000 @ ¥677 · 株式会社開生社2025-09-03 · bought 13,000 @ ¥674 · 株式会社開生社2025-09-02 · bought 13,000 @ ¥672 · 株式会社開生社2025-09-01 · bought 13,000 @ ¥664 · 株式会社開生社2025-08-29 · bought 13,000 @ ¥662 · 株式会社開生社2025-08-28 · bought 13,000 @ ¥662 · 株式会社開生社2025-08-27 · bought 13,000 @ ¥662 · 株式会社開生社2025-08-26 · bought 13,000 @ ¥665 · 株式会社開生社2025-08-25 · bought 13,000 @ ¥673 · 株式会社開生社2025-08-22 · bought 13,000 @ ¥674 · 株式会社開生社2025-08-21 · bought 13,000 @ ¥670 · 株式会社開生社2025-08-20 · bought 13,000 @ ¥665 · 株式会社開生社2025-08-19 · bought 13,000 @ ¥659 · 株式会社開生社2025-08-18 · bought 13,000 @ ¥653 · 株式会社開生社2025-08-12 · bought 13,000 @ ¥639 · 株式会社開生社2025-08-08 · bought 2,000,000 @ ¥635 · 株式会社開生社2025-07-11 · bought 7,173 @ ¥615 · individual filer
Bought SoldHover a dot for the trade
HolderPeriodNet sharesNet % of sharesAvg. filed priceRange
株式会社開生社2025-08-08 – 2025-10-16+2,546,000+4.36pt¥642.17¥635–685
individual filer2025-07-11 – 2025-07-11+7,173+0.01pt¥615¥615–615

Net shares and the average are our calculations. Prices are filed prices as stated by the filer, mostly for off-market trades; they are not market prices. Stock lending, custody transfers and option exercises are excluded from net shares. Every row via /v1/companies/4548/trades.

5% filings

Large shareholding reports on 4548
FiledFilerStakeChangeStated purpose
2025-10-23SHINGYO CO.,LTD.32.92%+1.00ptmanagement participation
2025-08-19SHINGYO CO.,LTD.31.92%+0.03ptmanagement participation
2025-08-18Mitsubishi UFJ Financial Group, Inc.3.35%−2.14ptstrategic holding
2025-08-18SHINGYO CO.,LTD.31.89%+3.53ptmanagement participation
2025-08-14SHINGYO CO.,LTD.31.89%+3.53ptmanagement participation
2025-08-06Invesco Asset Management (Japan) Limited4.78%−1.02pt—
2025-03-21Invesco Asset Management (Japan) Limited5.80%−1.13pt—
2024-11-05SHINGYO CO.,LTD.28.36%+0.01ptmanagement participation
2024-09-20Invesco Asset Management (Japan) Limited6.93%−0.62pt—
2024-09-03SHINGYO CO.,LTD.28.36%+0.01ptmanagement participation

Cross-shareholdings

From the annual report's status of shareholdings
Listed strategic holdings
5 issues
Book value
¥6.3bn
Sold in the year
— 3 issues
Bought in the year
— — issues
Mutual, both reports
5
Held by listed cos.
5
HoldsBook valueShares vs. prior yearMutual
KAKEN PHARMACEUTIAL CO., LTD. 4521¥2,080m0.0%both reports
SANTEN PHARMACEUTICAL CO.,LTD. 4536¥2,017m0.0%both reports
Maruzen Showa Unyu Co,.Ltd. 9068¥997m0.0%both reports
Mizuho Leasing Company, Limited 8425¥923m0.0%both reports
TECHNO RYOWA LTD. 1965¥284m0.0%both reports

Held by: KAKEN PHARMACEUTIAL CO., LTD. 4521, Mizuho Leasing Company, Limited 8425, SANTEN PHARMACEUTICAL CO.,LTD. 4536, Maruzen Showa Unyu Co,.Ltd. 9068, TECHNO RYOWA LTD. 1965

Purposes, all holdings and mutual flags via /v1/companies/4548/cross-holdings. Share changes include stock splits.

Major shareholders

As of fiscal year end 2026-03-31
ShareholderSharesRatio
株式会社開生社10,118,00018.53%
新業株式会社7,843,00014.36%
日本マスタートラスト信託銀行株式会社(信託口)4,114,0007.53%
株式会社日本カストディ銀行(信託口)1,347,0002.47%
科研製薬株式会社1,207,0002.21%
individual holder1,141,0002.09%
individual holder913,0001.67%
公益財団法人水谷糖質科学振興財団([氏名省略])828,0001.52%
明治安田生命保険相互会社688,0001.26%
ハイアール株式会社630,0001.15%

U.S. funds holding 4548

SEC Form N-PORT, reports to 2026-07-31

22 U.S. funds held 1,516,857 shares worth $7.0m.

FundSharesValue% of fundAs of
VANGUARD TOTAL INTERNATIONAL STOCK INDEX FUND
VANGUARD STAR FUNDS
510,460$2.4m0.000%2026-07-31
VANGUARD DEVELOPED MARKETS INDEX FUND
VANGUARD TAX-MANAGED FUNDS
350,434$1.6m0.000%2026-06-30
THE JAPANESE SMALL COMPANY SERIES
DFA INVESTMENT TRUST CO
178,100$0.8m0.021%2026-07-31
VANGUARD FTSE ALL-WORLD EX-US SMALL-CAP INDEX FUND
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS
128,341$0.6m0.004%2026-07-31
Old Westbury Small & Mid Cap Strategies Fund
Old Westbury Funds Inc
101,800$0.5m0.005%2026-07-31

Up to 25 funds per stock via the API.

Get this as JSON

GET /v1/companies/4548
GET /v1/companies/4548/financials
GET /v1/companies/4548/details
GET /v1/companies/4548/segments
GET /v1/companies/4548/voting
GET /v1/companies/4548/tender-offers
GET /v1/companies/4548/indicators
GET /v1/companies/4548/earnings-releases
GET /v1/events?ticker=4548
GET /v1/companies/4548/trades         
GET /v1/companies/4548/cross-holdings 
GET /v1/companies/4548/brief          

Plans from $9 a month · Documentation